Description

1H-1-Benzazepine-1-Carboxamide,2,3,4,5-Tetrahydro-n-1H-1,2,4-Triazol-3-Yl- is a high-purity, advanced pharmaceutical intermediate of significant interest in modern medicinal chemistry. This compound is valued for its role as a key synthetic building block in the development of novel therapeutic agents. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in the discovery and production of new drug candidates, particularly those targeting central nervous system and metabolic disorders.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel active pharmaceutical ingredients (APIs) for clinical research and development.
• Medicinal Chemistry Research: Used as a core scaffold or building block for constructing compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Drug Discovery Programs: Employed in the development of potential therapeutics targeting neurological pathways, given the benzazepine-triazole hybrid structure.
• Contract Manufacturing (CMO): Supplied to contract manufacturing organizations for the scale-up and cGMP production of investigational new drugs.
• Biochemical Research: Utilized as a tool compound or ligand in biochemical assays to study specific enzyme or receptor interactions.
• Academic Research: Used in university and institutional labs for advanced synthetic organic chemistry and pharmacology projects.

Basic Information

Product Name	1H-1-Benzazepine-1-Carboxamide,2,3,4,5-Tetrahydro-n-1H-1,2,4-Triazol-3-Yl-
CAS No.	585577-25-9
Molecular Formula	C12H13N5O
Molecular Weight	243.26 g/mol
Synonyms	N-(1H-1,2,4-Triazol-3-yl)-2,3,4,5-tetrahydro-1H-1-benzazepine-1-carboxamide; 2,3,4,5-Tetrahydro-1H-1-benzazepine-1-carboxamide, N-1H-1,2,4-triazol-3-yl-; 585577-25-9; Benzazepine-1-carboxamide, N-(1H-1,2,4-triazol-3-yl)-2,3,4,5-tetrahydro-1H-; 3-(2,3,4,5-Tetrahydro-1H-1-benzazepine-1-carboxamido)-1H-1,2,4-triazole
EINECS	Contact for details

Quality Control

Our 1H-1-Benzazepine-1-Carboxamide,2,3,4,5-Tetrahydro-n-1H-1,2,4-Triazol-3-Yl- is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and other critical parameters is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is moisture-sensitive (hygroscopic); keep the container tightly sealed in a dry environment.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.